InSysBio to announce the launch of QSP model of COVID-19

MOSCOW, RUSSIA - Jun 2, 2020 - InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces the launch of its fundamentally new project in response to the ongoing global threat, the open source QSP model of COVID-19

UCB and N-SIDE increase their strategic collaboration

LOUVAIN-LA-NEUVE, BELGIUM - Jun 2, 2020 - N-SIDE, provider of innovative software and strategic consulting services, announced that UCB has signed a 3-year agreement increasing their collaboration in clinical supply optimization

Domainex announces the appointment of Dr. Eddy Littler as non-executive Chairman

CAMBRIDGE, UK - Jun 2, 2020 - Following the retirement of Tony Brampton, Eddy Littler has been appointed as non-executive Chairman of Domainex Ltd

MeMed Receives CE Mark for Two Pioneering Technologies: The MeMed BV™ Test and MeMed Key™ Point-of-Need Platform

HAIFA, ISRAEL - Jun 2, 2020 -   MeMed Ltd., a leader in host response-based solutions, today announced that it has received a CE Mark in Europe for use of its diagnostic test MeMed BV™ and point-of-need platform MeMed Key™

Almac Clinical Technologies Introduces Simplify™, an Advanced IRT Solution Enabling Faster Clinical Trials Start-up

SOUDERTON, PA, UNITED STATES - Jun 1, 2020 - Almac Clinical Technologies, part of the Almac Group, today announced the availability of SimplifyTM, a next-generation Interactive Response Technology (IRT) solution that comes standard with an array of configurable functionality designed to accelerate the study start-up process with greater efficiency

Imvax Appoints Iphigenia Leonidou Koumenis as Head of Clinical Operations

PHILADELPHIA, PA, UNITED STATES - Jun 1, 2020 - PHILADELPHIA, PA (June 1, 2020)  – Imvax, Inc., a clinical-stage biotechnology company, today announced that Iphigenia (“Effie”) Leonidou Koumenis has been appointed as Head of Clinical Operations

Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer

NOTTINGHAM, UNITED KINGDOM - Jun 1, 2020 -   Albumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rAlb), announced today the strengthening of its Executive Leadership with the appointment of Gregor Kawaletz as Chief Commercial Officer, as of June 1st, 2020

Accumen Launches Hospital Lab Crisis Preparedness Program

PHOENIX, AZ - May 29, 2020 - Accumen Inc. is helping healthcare get better, faster. As an extension of its ongoing effort to provide resources that enable hospitals to manage every phase of the COVID-19 pandemic optimally, today Accumen launched its Lab Crisis Preparedness Program to help hospitals ensure their laboratories are able to meet the testing needs of their health system and surrounding communities

Long-Term Follow Up Data from Groundbreaking MINDACT Study Continues to Demonstrate Clinical Utility of MammaPrint®

IRVINE, CALIF., U.S., AND AMSTERDAM, NETHERLANDS - May 29, 2020 - Agendia, Inc., a world leader in precision oncology for breast cancer, today announced new data from MINDACT, the prospective randomized trial designed to further demonstrate the clinical utility of MammaPrint® risk scoring when determining a breast cancer patient’s need for chemotherapy

Shivom Launches FREE Informatics – Secure Health Data Sharing Solutions to Organisations Studying COVID-19.

LONDON, UNITED KINGDOM - May 29, 2020 -  Shivom Ventures Limited “Shivom” today announced the startup will be playing its part in combating the deadly coronavirus disease by offering researchers and pharmaceutical companies a 1-year free subscription to interrogate both viral and human genomes separately from RAW sequencing data

BOC Sciences Adds Featured SARS-CoV-2 Inhibitors for Drug Discovery

SHIRLEY, NY, UNITED STATES - May 29, 2020 - In recent days, BOC Sciences, one of the world’s leading chemical and pharmaceutical provider, announced to add more than 100 inhibitors of SARS-CoV-2 to its present inhibitor base to help the drug discovery of scientific research institutions during the COVID-19 pandemic

Elucid Digital Health reduces smart Pill Connect bottle to a smart cap dispenser which can fit on any medicine bottle

MANCHESTER, UNITED KINGDOM - May 28, 2020 -  

• The Elucid Digital Health screw on dispenser cap + app prompts compliance, messages patients, records temperature and humidity and provides real time reports for doctors or monitors

• Compliance in clinical trials is a serious problem with patients failing to comply - deteriorating as the trial progresses

• Non-compliance is estimated by the OECD to cause 200,000 premature deaths in Europe and estimated to cost E 125 billion in EU $105 billion in the US annually in avoidable hospitalisations, emergency care, and outpatient visitsx

CD Genomics Launches NGS Panels for SARS-CoV-2 Detection and Research

SHIRLEY, NY, UNITED STATES - May 20, 2020 - CD Genomics has developed a very comprehensive NGS panels for sequencing, coronaviruses detection, phylogenetic analysis and molecular characterization of the 2019 novel coronavirus (namely SARS-CoV-2, and the virus is responsible for COVID-19)

ERT helps medical researchers accelerate clinical trials with AI-assistance from Dynatrace

WALTHAM, MA, UNITED STATES - May 28, 2020 - Software intelligence company Dynatrace (NYSE: DT), today announced that ERT – a developer of software and devices used by medical researchers in 75% of FDA approved clinical trials in 2019 – is using Dynatrace® to automate DevOps processes, and speed up delivery of new applications, from an average of six weeks to as little as two weeks

Alfa Chemistry Testing Lab Releases Nano-products Safety Evaluation Services

NEW YORK, NY, UNITED STATES - May 28, 2020 - Earlier this month in May, 2020, Alfa Chemistry Testing Lab, a professional testing and analysis organization, announced to have released nano-products safety evaluation services for companies and agencies that are engaged with the development and application of nano-products

Research at MDI Biological Laboratory Explores Novel Pathways of Regeneration and Tumorigenesis

BAR HARBOR, ME, UNITED STATES - May 27, 2020 - Research by scientists at the MDI Biological Laboratory in Bar Harbor, Maine, is opening up new approaches to promoting tissue regeneration in organs damaged by disease or injury

Biodesy Announces Corporate Name Change to BlueLight Therapeutics

SOUTH SAN FRANCISCO, CA, UNITED STATES - May 27, 2020 - Biodesy Inc. today announced that it has changed its corporate name to BlueLight Therapeutics Inc., effective May 20, 2020, and appointed drug discovery expert Mark Gallop, PhD, as Chief Scientific Officer

AI & Medicine — An Expert in AI-aided Drug Discovery and Medical Applications

NEW YORK, NY, UNITED STATES - May 27, 2020 - Recently founded, the New York-based company AI & Medicine is an expert in the field of AI-Powered drug discovery, personalized healthcare and various medical applications

Alfa Chemistry Offers PEG linkers for the Science Community in Bioconjugation and Pegylation

NEW YORK, NY, UNITED STATES - May 27, 2020 - Earlier this month in May, 2020, the world's leading chemical supplier Alfa Chemistry announced that a total of close to 800 PEG linker products are now available for its customers worldwide, including acid PEG linkers, alkyl PEG linkers, amino PEG linkers, azido PEG linkers, benzyl PEG linkers, biotin PEG linkers, fmoc PEG linkers, NHBoc PEG linkers, NHS ester PEG linkers, t-butyl ester PEG linkers, THP PEG linkers, and other PEG Linkers

2bPrecise Solution Wins 2020 MedTech Breakthrough Award

PITTSBURGH, PA, UNITED STATES - May 26, 2020 - 2bPrecise, an EHR-agnostic, cloud-based precision medicine platform, has been recognized as the “Best Overall Genomics Solution” in the fourth annual MedTech Breakthrough Awards program